These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. TH1/TH2 cytokine analysis in Iranian renal transplant recipients. Amirzargar A, Lessanpezeshki M, Fathi A, Amirzargar M, Khosravi F, Ansaripour B, Nikbin B. Transplant Proc; 2005 Sep; 37(7):2985-7. PubMed ID: 16213281 [Abstract] [Full Text] [Related]
24. [Significance of sequential monitoring of serum IL-18 in renal allograft recipients]. Liu Z, Wang LX, Wang FL, Qin WJ, Zhang G, Wang H, Yuan JL. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Nov; 24(11):1082-3. PubMed ID: 18992197 [Abstract] [Full Text] [Related]
25. CC-chemokine RANTES is increased in serum and urine in the early post-transplantation period of human renal allograft recipients. Baer PC, Koziolek M, Fierlbeck W, Geiger H. Kidney Blood Press Res; 2005 Nov; 28(1):48-54. PubMed ID: 15509902 [Abstract] [Full Text] [Related]
27. [Role of IL-8 and defensins in pathogenesis of chronic glomerulonephritis and pyelonephritis]. Rebenok AZh, Tikhonov II, Chizh AS. Ter Arkh; 1999 Nov; 71(8):62-7. PubMed ID: 10515041 [Abstract] [Full Text] [Related]
28. Changes in the serum levels of interleukin-17/interleukin-23 during acute rejection in liver transplantation. Fábrega E, López-Hoyos M, San Segundo D, Casafont F, Pons-Romero F. Liver Transpl; 2009 Jun; 15(6):629-33. PubMed ID: 19479806 [Abstract] [Full Text] [Related]
29. The value of posttransplant monitoring of interleukin (IL)-2, IL-3, IL-4, IL-6, IL-8, and soluble CD23 in the plasma of renal allograft recipients. Kutukculer N, Clark K, Rigg KM, Forsythe JL, Proud G, Taylor RM, Shenton BK. Transplantation; 1995 Feb 15; 59(3):333-40. PubMed ID: 7871561 [Abstract] [Full Text] [Related]
30. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection. Ayed K, Abdallah TB, Bardi R, Abderrahim E, Kheder A. Transplant Proc; 2006 Sep 15; 38(7):2300-2. PubMed ID: 16980071 [Abstract] [Full Text] [Related]
34. Pretransplant soluble CD30 level has limited effect on acute rejection, but affects graft function in living donor kidney transplantation. Kim MS, Kim HJ, Kim SI, Ahn HJ, Ju MK, Kim HJ, Jeon KO, Kim YS. Transplantation; 2006 Dec 27; 82(12):1602-5. PubMed ID: 17198243 [Abstract] [Full Text] [Related]
35. Association of pretransplant soluble glycoprotein 130 (sgp130) plasma levels and posttransplant acute tubular necrosis in renal transplant recipients. Sadeghi M, Daniel V, Lahdou I, Döhler B, Naujokat C, Renner FC, Weimer R, Fonouni H, Mehrabi A, Schmidt J, Schenk M, Zeier M, Opelz G. Transplantation; 2009 Jul 27; 88(2):266-71. PubMed ID: 19623024 [Abstract] [Full Text] [Related]
36. [Dynamic monitoring of serum soluble HLA class I antigens in renal transplant recipients]. Xu J, Cao Q, Wu D, Ma J, Yu L. Zhonghua Wai Ke Za Zhi; 1999 Nov 27; 37(11):657-9. PubMed ID: 11829918 [Abstract] [Full Text] [Related]
37. Relationship between serum and urine interleukin-6 elevations and renal scarring in children with acute pyelonephritis. Sheu JN, Chen MC, Chen SM, Chen SL, Chiou SY, Lue KH. Scand J Urol Nephrol; 2009 Nov 27; 43(2):133-7. PubMed ID: 18972261 [Abstract] [Full Text] [Related]
38. Serum interleukin-2 receptor levels measured by enzyme immunoassay in heart and kidney transplanted patients. De Maria R, Zucchelli GC, Clerico A, Carmellini M, Di Stefano R, Masini S, Caroli A, Mian M, Bertelli A. Int J Tissue React; 1989 Nov 27; 11(5):261-5. PubMed ID: 2699610 [Abstract] [Full Text] [Related]